PAPER Takekiyo T, Yamada N, Nakazawa CT, Amo T, Asano A, Yoshimura Y
SEARCH RESULTS
310 RESULTS
PAPER Chu Y, Bartus RT, Manfredsson FP, Olanow CW, Kordower JH
Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease.
Brain. 2020 Mar 1;143(3):960-975. PubMed: 32203581PAPER Peng C, Trojanowski JQ, Lee VM
Protein transmission in neurodegenerative disease.
Nat Rev Neurol. 2020 Apr;16(4):199-212. Epub 2020 Mar 23 PubMed: 32203399PAPER Lemprière S
Exosomal α-synuclein as a biomarker for Parkinson disease.
Nat Rev Neurol. 2020 May;16(5):242-243. PubMed: 32203397PAPER Stok R, Ashkenazi A
Lipids as the key to understanding α-synuclein behaviour in Parkinson disease.
Nat Rev Mol Cell Biol. 2020 Jul;21(7):357-358. PubMed: 32203270PAPER Sun Y, Hou S, Zhao K, Long H, Liu Z, Gao J, Zhang Y, Su XD, Li D, Liu C
Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson's disease familial A53T mutation.
Cell Res. 2020 Apr;30(4):360-362. Epub 2020 Mar 12 PubMed: 32203130PAPER Fearon C, Farrell MA
Disease-Specific Strains of α-Synuclein in Multiple System Atrophy and Parkinson's Disease: But Why?
Mov Disord. 2020 May;35(5):756-757. Epub 2020 Mar 23 PubMed: 32202672PAPER Jia L, Zhao W, Wei W, Guo X, Wang W, Wang Y, Sang J, Lu F, Liu F
Expression and purification of amyloid β-protein, tau, and α-synuclein in Escherichia coli: a review.
Crit Rev Biotechnol. 2020 Jun;40(4):475-489. Epub 2020 Mar 22 PubMed: 32202164PAPER Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N
Variants in saposin D domain of prosaposin gene linked to Parkinson's disease.
Brain. 2020 Apr 1;143(4):1190-1205. PubMed: 32201884PAPER Ma J, Feng B, Kong D, He J, Guo R, Amponsah AE, Zhang W, Zhang S, Lv F, Song Y, Liu A, Cui H
Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS).
Stem Cell Res. 2020 Apr;44:101760. Epub 2020 Mar 13 PubMed: 32203916PAPER Morrice JR, Gregory-Evans CY, Shaw CA
Investigating microglia during motor neuron degeneration using a zebrafish model.
Micron. 2020 Jun;133:102852. Epub 2020 Feb 20 PubMed: 32203887PAPER Bauckneht M, Lai R, Miceli A, Schenone D, Cossu V, Donegani MI, Raffa S, Borra A, Marra S, Campi C, Orengo A, Massone AM, Tagliafico A, Caponnetto C, Cabona C, Cistaro A, Chiò A, Morbelli S, Nobili F, Sambuceti G, Piana M, Marini C
Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images.
EJNMMI Res. 2020 Mar 23;10(1):23. PubMed: 32201914PAPER Zhu S, Wang X, Zheng Z, Zhao XE, Bai Y, Liu H
Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats.
J Pharm Biomed Anal. 2020 Jun 5;185:113263. Epub 2020 Mar 17 PubMed: 32203895PAPER Fernández-Cabello S, Kronbichler M, Van Dijk KR, Goodman JA, Spreng RN, Schmitz TW, Alzheimer’s Disease Neuroimaging Initiative
Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
Brain. 2020 Mar 1;143(3):993-1009. PubMed: 32203580PAPER Agosta F, Canu E, Filippi M
Virtual reality and real-time neurofeedback functional MRI: a breakthrough in foreseeing Alzheimer's disease?
Brain. 2020 Mar 1;143(3):722-726. PubMed: 32203574Current Filters
- Date Range : Mar 2020 to Mar 2020 x